Your session is about to expire
← Back to Search
Catheterization for Prostate Cancer
Study Summary
This trial will use PET to compare the prostate uptake of 68Ga-PSMA-11 delivered intra-arterially to that of the same agent delivered intravenously.
- Prostate Cancer
- Prostate Adenocarcinoma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there specific eligibility requirements to participate in this experiment?
"Only men with prostate cancer that are between 18-80 years old can be a part of this study--of which there are only 5 slots available."
For what reasons is Catheterization commonly used?
"Tumor antigens are most often treated with Catheterization, though this method is also useful for treating metastasis, positron emission tomography, and prostate cancer."
Are there any other ongoing or previous research projects that have used Catheterization?
"There are a total of 13 clinical studies being conducted that focus on catheterization with one of those trials currently in Phase 3. The majority of these research projects are taking place in Rochester, Minnesota; however, there are 17 clinical locations across the United States running these types of trials."
Does the age limit for participation in this trial extend past 80 years old?
"Eligibility requirements for this trial state that potential participants must be between 18-80 years old. There are 77 other clinical trials underway for individuals below 18 and 1,377 for seniors above 65."
Share this study with friends
Copy Link
Messenger